Pharmaceutical
Health
Therapy

Zogenix

2,126

$29.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+0.41%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Zogenix and other stocks, options, ETFs, and crypto commission-free!

About ZGNX

Zogenix, Inc. Common Stock, also called Zogenix, is a pharmaceutical company. Read More It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.

CEO
Stephen James Farr
Employees
141
Headquarters
Emeryville, California
Founded
2006
Market Cap
1.62B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.85M
High Today
$29.98
Low Today
$28.59
Open Price
$29.26
Volume
828.42K
52 Week High
$57.22
52 Week Low
$16.65

Collections

Pharmaceutical
Health
Therapy
Technology

ZGNX News

MarketWatchJun 29

Zogenix's shares rise on FDA approval of seizure drug

Shares of Zogenix Inc. ZGNX, -9.42% gained 2.9% in premarket trading on Monday, following the news on Friday that the Food and Drug Administration had approved
0

ZGNX Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 6, After Hours

You May Also Like

AEP
CIFAF
LCA
ABG
JKE
GDP
PACB
NWPX
TENX
XLRN
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ZGNX

Market Price$29.19
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Zogenix stock and options commission-free.
LearnBlogCareersHelpLog InSign Up